Total Payments
$11,968
2024 Payments
$4,508
Companies
15
Transactions
507
Medicare Patients
157
Medicare Billing
$29,755
Payment Breakdown by Category
Food & Beverage$9,624 (80.4%)
Consulting$1,990 (16.6%)
Education$354.24 (3.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,624 | 498 | 80.4% |
| Consulting Fee | $1,990 | 2 | 16.6% |
| Education | $354.24 | 7 | 3.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $1,953 | 8 | $0 (2024) |
| Alkermes, Inc. | $1,320 | 55 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $1,307 | 80 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $1,214 | 44 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,109 | 65 | $0 (2024) |
| ITI, Inc. | $876.05 | 33 | $0 (2023) |
| Vanda Pharmaceuticals Inc. | $796.62 | 45 | $0 (2024) |
| Allergan Inc. | $705.29 | 48 | $0 (2019) |
| ABBVIE INC. | $656.99 | 34 | $0 (2024) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $541.63 | 20 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,508 | 113 | E.R. Squibb & Sons, L.L.C. ($1,953) |
| 2023 | $1,459 | 60 | ITI, Inc. ($339.00) |
| 2022 | $1,152 | 51 | ITI, Inc. ($295.22) |
| 2021 | $607.84 | 28 | ITI, Inc. ($241.83) |
| 2020 | $322.08 | 12 | Teva Pharmaceuticals USA, Inc. ($85.50) |
| 2019 | $1,502 | 91 | Otsuka America Pharmaceutical, Inc. ($369.77) |
| 2018 | $977.78 | 74 | Janssen Pharmaceuticals, Inc ($241.89) |
| 2017 | $1,441 | 78 | Allergan Inc. ($447.58) |
All Payment Transactions
507 individual payment records from CMS Open Payments — Page 1 of 21
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $1,840.00 | General |
| 12/19/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $24.36 | General |
| Category: Neuropsychiatry | ||||||
| 12/17/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $17.74 | General |
| Category: SCHIZOPHRENIA | ||||||
| 12/12/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $17.74 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/10/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $20.35 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/09/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $24.15 | General |
| Category: SCHIZOPHRENIA | ||||||
| 12/06/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $23.14 | General |
| Category: Psychology/Psychiatric | ||||||
| 12/05/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $28.45 | General |
| Category: PSYCHIATRY | ||||||
| 12/03/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $14.60 | General |
| Category: Neuropsychiatry | ||||||
| 12/02/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $13.06 | General |
| Category: CNS | ||||||
| 11/26/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $21.60 | General |
| Category: SCHIZOPHRENIA | ||||||
| 11/25/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $28.40 | General |
| Category: Psychiatry/Psychology | ||||||
| 11/22/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $14.28 | General |
| Category: PSYCHIATRY | ||||||
| 11/20/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $5.46 | General |
| Category: Neuropsychiatry | ||||||
| 11/19/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $24.97 | General |
| Category: SCHIZOPHRENIA | ||||||
| 11/19/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $23.26 | General |
| Category: PSYCHIATRY | ||||||
| 11/18/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $19.90 | General |
| Category: Neurology | ||||||
| 11/18/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $4.29 | General |
| Category: Psychiatry/Psychology | ||||||
| 11/15/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $23.73 | General |
| Category: Neuroscience | ||||||
| 11/14/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $20.57 | General |
| 11/12/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $15.99 | General |
| Category: Neuropsychiatry | ||||||
| 11/12/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $15.18 | General |
| 11/08/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $32.05 | General |
| Category: PSYCHIATRY | ||||||
| 11/07/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $27.77 | General |
| Category: PSYCHIATRY | ||||||
| 11/05/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $9.18 | General |
| Category: CNS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 29 | 58 | $11,286 | $4,260 |
| 2022 | 2 | 33 | 71 | $18,210 | $7,369 |
| 2021 | 2 | 33 | 70 | $13,400 | $7,233 |
| 2020 | 3 | 62 | 128 | $25,425 | $10,894 |
Total Patients
157
Total Services
327
Medicare Billing
$29,755
Procedure Codes
9
All Medicare Procedures & Services
9 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 14 | 31 | $8,370 | $3,008 | 35.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 15 | 27 | $2,916 | $1,251 | 42.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 20 | 55 | $14,850 | $5,990 | 40.3% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 13 | 16 | $3,360 | $1,379 | 41.0% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 18 | 47 | $8,225 | $4,876 | 59.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 15 | 23 | $5,175 | $2,357 | 45.5% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 28 | 76 | $13,300 | $6,834 | 51.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 17 | 35 | $7,875 | $2,290 | 29.1% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2020 | 17 | 17 | $4,250 | $1,770 | 41.7% |
About Dr. John Sullivan, M.D
Dr. John Sullivan, M.D is a Psychiatry healthcare provider based in San Diego, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/22/2007. The National Provider Identifier (NPI) number assigned to this provider is 1851597389.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Sullivan, M.D has received a total of $11,968 in payments from pharmaceutical and medical device companies, with $4,508 received in 2024. These payments were reported across 507 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($9,624).
As a Medicare-enrolled provider, Sullivan has provided services to 157 Medicare beneficiaries, totaling 327 services with total Medicare billing of $29,755. Data is available for 4 years (2020–2023), covering 9 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location San Diego, CA
- Active Since 06/22/2007
- Last Updated 12/06/2011
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1851597389
Products in Payments
- CAPLYTA (Drug) $1,418
- REXULTI (Drug) $1,286
- VRAYLAR (Drug) $1,109
- ARISTADA (Drug) $927.31
- INVEGA SUSTENNA (Drug) $635.47
- INGREZZA (Drug) $522.24
- PERSERIS (Drug) $513.65
- UZEDY (Drug) $490.13
- AUSTEDO (Drug) $443.35
- Fanapt (Drug) $350.62
- FANAPT (Drug) $283.03
- INVEGA TRINZA (Drug) $271.54
- ABILIFY MAINTENA (Drug) $267.55
- SPRAVATO (Drug) $201.82
- ABILIFY ASIMTUFII (Drug) $146.91
- Aristada 441 mg (Drug) $135.78
- LYBALVI (Drug) $106.70
- Hetlioz (Drug) $83.91
- HETLIOZ (Drug) $79.06
- COBENFY (Drug) $70.78
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in San Diego
Dr. Jonathan Meyer, M.d, M.D
Psychiatry — Payments: $2.0M
Psychiatry $2.0M
Dr. Sanjai Rao, M.d, M.D
Psychiatry — Payments: $633,149
Psychiatry $633,149
Dr. Murray Stein, M.d., M.p.h, M.D., M.P.H
Psychiatry — Payments: $115,110
Psychiatry $115,110
Dr. Mukesh Sanghadia, M.d., Mrcpsych(Uk), M.D., MRCPSYCH(UK)
Psychiatry — Payments: $82,626
Psychiatry $82,626
Dr. Neil Richtand, M.d, M.D
Psychiatry — Payments: $76,458
Psychiatry $76,458
Clark Smith, Md, MD
Psychiatry — Payments: $72,261
Psychiatry $72,261